Bioelectronics Corp (BIEL)

[Simpsonly]

Now you're getting my attention Dogman - my assessment for a long while has been that when BIEL is finished using its revolving financing model in order to stay alive, during the arduous regulatory process, it will do a reverse when also profitable for one purpose and only one purpose, to shift the company to an exchange of high repute, which will be a substantial attractor for institutional and retail investors, the former which will never invest in a company listed on the Pink Sheets and the latter, only very reluctantly. Your theory therfor, in my mind, has merit, thanks

With BIEL having been added yesterday, as published, to the April Tariff for the UK NHS universal healthcare insurance system, you know when . . . . imminent